US 11,690,822 B2Granted

Method for treating non-compaction cardiomyopathy

AssigneesExcelsior Pharmatech Labs, National Taiwan University

InventorsWen-Pin Chen, Mei-Hwan Wu, Hong-Nerng Ho

Life of this patent

Estimating the term…

Abstract

A method for treating a subject suffering from non-compaction cardiomyopathy (NCC), by administering to the subject suffering from NCC a pharmaceutical composition having a therapeutically effective amount of a EZH2 downregulator including the statin.

Claims11

Dependent claims

A method for treating a subject suffering from non-compaction cardiomyopathy, comprising administering to the subject suffering from non-compaction cardiomyopathy a pharmaceutical composition comprising a therapeutically effective amount of a EZH2 downregulator.

Dependencies are inferred from the claim text.

Facts

Application: 15/734,315Filed 23 May 2019 · us provisional application
Priority: 3 Jun 2018
Published: US 2021/0220327 A122 Jul 2021
Granted: 4 Jul 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/366
Lactones: having six-membered rings, e.g. delta-lactones
A61P 9/04
Drugs for disorders of the cardiovascular system: inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
A61K 9/0024
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in…
A61K
Medicines and medical preparations

Family

Application62/679,968Us provisional application · filed 3 Jun 2018
US 2021/0220327 A1Pre-grant publication · published 22 Jul 2021
US 11,690,822 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results